Borouge International has appointed Roland Janssen as Chief Commercial Officer, effective October 1, 2026. Janssen will be based at Borouge International’s headquarters in Vienna.
Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026. Michael Quirmbach to transition from President & CEO to Board Member and Senior Advisor.
Fecc has elected Peter Bigler, a board member of Harke Group, as its new Association President, effective immediately.
Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027.
Until further notice, Rettig is taking over the duties of Christian Kullmann, who is recovering in the coming weeks from a recent serious, unplanned surgery.
Samanta Cimitan will join Lonza as Chief Commercial Officer (CCO), Senior Vice President, and a member of the Extended Executive Committee, effective January 1, 2027.
As Managing Director, Lisa will provide strategic leadership for BASF in the UK, supporting the company’s licence to operate and ensuring the business continues to contribute to BASF’s long-term success.
Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.
Rentschler Biopharma has appointed Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
Lars Wallstein will join the management team of the German chemical distributor Oqema effective July 1, 2026.
What does it feel like to finally walk into a room where you belong? Vera-Maria Pitot on how Women in Chemicals is reshaping leadership — and why the impact must go far beyond one week a year.
Symeres, a transatlantic CRDMO for drug discovery and development, announced the appointment of Henning Steinhagen as Chief Executive Officer.
Unither Pharmaceuticals welcomes Henrik Krüpper as Chief Executive Officer of the Group, starting May 4.
Dow CEO Jim Fitterling will step down to become Executive Chair, while current COO Karen S. Carter has been appointed CEO effective July 1, 2026. The move follows a multi-year succession process.
CEFIC recently announced the promotion of Miguel Prieto Arranz to Executive Director, Specialty Chemicals, as of 1 April 2026.
The chemical industry's workforce is rapidly approaching retirement age. We need fresh talent, fast.
Sandoz has announced the creation of a new biosimilar development, manufacturing and supply unit.
Symbiosis Pharmaceutical Services has appointed experienced commercial leader Joanne Anderson as Chief Commercial Officer to drive global growth following recent capacity investments and expansion plans.
WeylChem will discontinue production at its Elgin, USA site and has established a new US sales office led by Cameron Young, Sales and New Business Development Director.
The IMCD Group has appointed Hedwig Koopmans as Managing Director of IMCD Switzerland with effect from April 1, 2026.
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
Belén Garijo to become Chief Executive Officer of Sanofi.
Veit Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology as well as automation in production from April 1, 2026.
The Society of Chemical Manufacturers & Affiliates (SOCMA) recently announced that Jenn Klein has been selected as the organization's next President & Chief Executive Officer after a national search.
A.N. Sreeram, Senior VP and Chief Technology Officer, will retire from Dow at the end of June. Andre Argenton will move to the newly created role of Chief Technology & Sustainability Officer.
Seasoned Syensqo business leader to guide the company’s next chapter.
Women In Chemicals announced that Amber Thichangthong will step down as Executive Director at the end of 2025 and will be succeeded by experienced nonprofit leader Katie Hess effective January 1, 2026.
Markus Kamieth, CEO of BASF, has been appointed the new President of the European Chemical Industry Council CEFIC, effective January 1, 2026.
As of January 1, 2026, Christoph Garbotz will be Managing Director for IMCD Germany.
Emmanuel Colette will assume global leadership of IMCD's Food & Nutrition business group with effect from 1 March 2026.
Bachem's Board of Directors has appointed Anne-Kathrin Stoller, the former Head of Bachem Americas and previously the company's CMO for many years, as the new CEO effective January 1, 2026.
Sterling Pharma Solutions announced the appointment of Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025.
Syensqo has announced that Ilham Kadri will step down as CEO on January 1, 2026, with Mike Radossich, current President of Performance & Care, set to assume the role and lead the company into its next growth phase.
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
